Modified Release Neurology Therapeutics Report 2024 - Neurology Therapeutics Advance with Modified R
DUBLIN--(BUSINESS WIRE)--The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining...
Polyactive Octoplus Xbrane Bipharma Depofoam Pacira Q Sphera Midatech Pharma Recipharm Avadel Fluidcrystal Camarus
Source: pharmiweb.com